"The NG Biotech rapid test is CE Marked for professional use for COVID-19 testing in Europe."
From the ASX announcement on April 15 headed
"Atomo receives additional order for COVID-19 testdevicesCOVID-19 test devices ordered to date:947,200"
So the NG Biotech test is available for use in Europe.
Number of cases in Europe = 1,168,284
Number of people in Europe = 741,000,000
Seems like a good opportunity to me for sales in Europe alone.
- Forums
- ASX - By Stock
- AT1
- 50% margin ? The product
50% margin ? The product, page-52
Featured News
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $14.06M |
Open | High | Low | Value | Volume |
2.3¢ | 2.5¢ | 2.2¢ | $24.03K | 1.041M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 541875 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 699206 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 541875 | 0.021 |
11 | 821549 | 0.020 |
7 | 420742 | 0.019 |
4 | 430053 | 0.018 |
4 | 910888 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 699206 | 3 |
0.024 | 170000 | 3 |
0.025 | 1332555 | 4 |
0.026 | 748949 | 3 |
0.027 | 643000 | 2 |
Last trade - 15.56pm 13/11/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |